FDA product code SBY: High Throughput Sequencing Based Tumor Profiling Test Of Circulating Cell-Free Nucleic Acids
SBY is the FDA product code for high throughput sequencing based tumor profiling test of circulating cell-free nucleic acids. It is a Class II device, regulated under 21 CFR 866.6085 and reviewed by the Pathology panel. FDA has cleared 1 510(k) submission under SBY, 1 in the last five years. The average 510(k) review took 216 days (median 216); 216 days on average over the last three years. 1 De Novo request was granted under it.
Definition
A high throughput sequencing based tumor profiling test of circulating cell-free nucleic acids is a qualitative in vitro diagnostic test intended for next generation sequencing analysis of circulating cell-free nucleic acids from plasma samples collected from peripheral whole blood to detect mutations in a panel of targeted genes to aid in the management of previously diagnosed cancer patients by qualified health care professionals. The results of the test are not prescriptive or conclusive for use of any specific therapeutic product.
Classification
| Field | Value |
|---|---|
| Device name | High Throughput Sequencing Based Tumor Profiling Test Of Circulating Cell-Free Nucleic Acids |
| Device class | Class II |
| Regulation | 21 CFR 866.6085 |
| Review panel | PA — Pathology |
| Medical specialty | Pathology |
| Premarket route | 510(k) |
510(k) clearances per year for SBY
| Year | Clearances | Avg. review days |
|---|---|---|
| 2026 | 1 | 216 |
Compare with all 510(k) review times · Search every SBY clearance
Top SBY applicants
| Applicant | Clearances | Latest |
|---|---|---|
| Life Technologies Corporation | 1 | 2026-10-15 |
Most recent SBY clearances
| 510(k) | Applicant | Device | Decision date | Review days |
|---|---|---|---|---|
| K260827 | Life Technologies Corporation | Oncomine Dx Express Test | 2026-10-15 | 216 |
Recalls for SBY devices
FDA recall records list no recalls for product code SBY.
Frequently asked questions
What is FDA product code SBY?
SBY is the FDA product code for high throughput sequencing based tumor profiling test of circulating cell-free nucleic acids. It is a Class II device, regulated under 21 CFR 866.6085 and reviewed by the Pathology panel.
What device class is SBY?
Class II, regulation 21 CFR 866.6085. Typical premarket route: 510(k).
How long does a 510(k) take for product code SBY?
Across 1 cleared submissions the average was 216 days from receipt to decision (median 216).
Which companies have the most SBY clearances?
Life Technologies Corporation (1).
Next steps
- Run an FDA pathway report with predicate devices for product code SBY
- Run a recall and safety report across every SBY manufacturer
- Watch product code SBY for new clearances and recalls
Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.
All Pathology product codes · FDA product code lookup · 510(k) database search · 510(k) review times